Gelesis, Inc. Receives $16,000,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=503ee5fa-ccde-481d-88a2-4c402cf9340e&Preview=1
-
Date
1/3/2008
-
Company Name
Gelesis, Inc.
-
Mailing Address
222 Berkeley St Boston, MA 02116
-
Company Description
Gelesis is a Research and Development company for the treatment of obesity.
-
Website
Undisclosed
-
Transaction Type
Venture Equity
-
Transaction Amount
$16,000,000
-
Transaction Round
Series A
-
Proceeds Purposes
Proceeds purposes were not disclosed.
-
M&A Terms
-
Venture Investor
OrbiMed
-
Venture Investor
OrbiMed
-
Venture Investor
PureTech Ventures
-
Venture Investor
Queensland Investment Corporation
Add Your Thoughts
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.